Comorbidity and healthcare utilisation in persons with incident systemic lupus erythematosus followed for 3 years after diagnosis: analysis of a claims data cohort

• Published in: Lupus science & medicine Vol. 8; no. 1; p. e000526
• Main Authors: Albrecht, Katinka, Redeker, Imke, Aringer, Martin, Marschall, Ursula, Strangfeld, Anja, Callhoff, Johanna
• Format: Journal Article
• Language: English
• Published: England Lupus Foundation of America 25.08.2021; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: Age; Arthritis; Autoimmune Diseases; Chronic illnesses; Cohort Studies; Comorbidity; Diabetes; Disease; Epidemiology and Outcomes; Evidence-based medicine; health care; Health insurance; health services research; Health services utilization; Hospitals; Humans; Lupus; lupus erythematosus; Lupus Erythematosus, Systemic - complications; Osteoporosis; outcome assessment; Patient Acceptance of Health Care; Population; Sick leave; systemic; Germany; health services research; systemic; outcome assessment; lupus erythematosus; health care
• ISSN: 2053-8790; 2053-8790
• DOI: 10.1136/lupus-2021-000526

ObjectiveTo analyse comorbidity and healthcare utilisation in individuals with SLE.MethodsA cohort of individuals with incident SLE diagnosis in 2016 were investigated using claims data from a German statutory health insurance fund. Concomitant diagnoses, medical prescriptions, hospitalisation and sick leave were analysed in the year prior to diagnosis and during a 3-year follow-up in comparison with age-matched and sex-matched controls (1) without autoimmune diseases and (2) with incident diabetes mellitus. Sensitivity analyses were performed excluding cases with additional autoimmune diagnoses and without prescription of antimalarials.ResultsAmong 571 individuals with SLE, hypertension (48%), depression (30%), hyperlipidaemia (25%), osteoarthritis (25%) and osteoporosis (20%) were the most frequent comorbidities in 2016. Cerebrovascular disease was documented in 9.6%. The number of drugs (mean 9.6, ∆+6.2), hospitalisation (40%, ∆+27%) and days on sick leave (median 46 days, ∆+27 days) increased significantly in the first year with SLE diagnosis. Individuals with SLE were more frequently hospitalised and had more medications compared with both control groups (all p<0.001). The increase in comorbidity diagnoses was low in controls without autoimmune diseases, while controls with diabetes showed a more pronounced increase in cardiovascular risk factors, but less in osteoporosis and cerebrovascular disease. Sensitivity analyses showed comparable results.ConclusionComorbidities are frequently detected at the time of diagnosis of SLE. High numbers of drug prescriptions and hospitalisation following SLE diagnosis reflect the comprehensive disease burden. The comparison with incident diabetes shows that differences with controls without autoimmune disease are overestimated by detection bias.